Delisted
Stopped trading. Fund positions aren't valued until we confirm what happened.
KINNATE BIOPHARMA INC
KNTE·49705R105·US·Common Stock
KNTE (KINNATE BIOPHARMA INC) is held by 0 institutional investors as of Q2 2024.
0
Holders
$0
Total Value
0%
Consensus
13F: Insider & Congress: Updated regularly
No verdict yet — fewer than 2 funds hold KNTE.
Top Holders
Checking access…
| Action | ||||||
|---|---|---|---|---|---|---|
Exited | 0(-100.0%) | $941,962 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $4.8M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $277,802 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $30,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $57,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $61,677 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $63,392 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $4,788 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $7,801 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $107,730 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $370,256 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $37,732 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $89,088 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $136,192 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $305,490 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $16,657 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $10,911 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $415,197 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $711,164 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $649,569 | 0.0% | — | 0 |
Showing 1-20 of 29
1 / 2
KNTEKINNATE BIOPHARMA INCContinue exploring
Similar stocks
FISVFiserv Inc334 holders · $21.5B
SPYSPDR S&P 500 ETF Trust294 holders · $348.2B
IVViShares Core S&P 500 ETF262 holders · $566.9B
QQQInvesco QQQ Trust Series 1246 holders · $125.8B
VOOVANGUARD S&P500 INDEX ETF245 holders · $264.7B
IWMiShares Russell 2000 ETF242 holders · $68.1B
GLDSPDR GOLD TRUST GOLD SHS237 holders · $34.1B
XLFFinancial Select Sector SPDR Fund224 holders · $31.5B
XLEEnergy Select Sector SPDR Fund223 holders · $17.3B
EFAiShares MSCI EAFE ETF221 holders · $47.1B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer